에 대한 최신 뉴스 Under Armour (NYSE:UAA) 주식

Under Armour

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Asia

Equities

News

Markets

ADDYY

DECK

PMMAF

도널드 트럼프가 제안한 수입 관세가 운동화 제조업체와 소매업체에 큰 영향을 미칠 것이라는 우려가 운동화 업계를 휩쓸고 있다. 이러한 잠재적인 정책은 특히 아시아 제조 허브에 크게 의존하는 기업들에게 영향을 미칠 수 있다.무슨 일이 일어났을까? 트럼프 대통령이 모든 수입품에 20% 관세를 부과하고 특히 중국산 제품에 60%의 고율 관세를 부과하겠다고 밝힌 후 업계 리더들은 충격에 대비하고 있다. 이미 상당한 수입 관세를 부담하고 있는 신발 부문은 생산 비용이 더욱 급증할 수 있다.

트럼프 2기 행정부 들어서면 나이키 운동화 비싸질까?

Under Armour Inc

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage 69B Vs 67B Est.; 78B Prior

Wells Fargo analyst Joe O'Dea maintains Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) with a Overweight and raises the price target from $84 to $90.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Johnson Controls Intl, Raises Price Target to $90

Wells Fargo analyst Jason Haas maintains Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) with a Overweight and raises the price target from $2200 to $2400.

FICO

Wells Fargo Maintains Overweight on Fair Isaac, Raises Price Target to $2400

Cantor Fitzgerald analyst Deepak Mathivanan maintains Tripadvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) with a Underweight and lowers the price target from $12 to $11.

TRIP

Cantor Fitzgerald Maintains Underweight on Tripadvisor, Lowers Price Target to $11

Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) reported its Q3 earnings results on Monday, October 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Welltower beat estimated earnings by 7.000000000000001%, reporting an EPS of $1.11 versus an estimate of $1.04.
Revenue was up $394.00 million from the same period last year.
<h3>Historical Earnings Summary</h3>
Last quarter the company beat on EPS by $0.04 which was followed by a 1.0% increase in the share price the next day.
Here's a look at Welltower's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.04</td>
<td>1.01</td>
<td>0.94</td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.11</td>
<td>1.05</td>
<td>1.01</td>
<td>0.96</td>
<td>0.92</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.95B</td>
<td>1.89B</td>
<td>1.81B</td>
<td>1.75B</td>
<td>1.63B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>2.06B</td>
<td>1.82B</td>
<td>1.56B</td>
<td>1.75B</td>
<td>1.66B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Welltower management provided guidance for FY 2024, expecting earnings between $4.27 and $4.33 per share.
<h3>Comparison of Competitors' Recent Earnings</h3>
With Welltower's earnings data now available, it's crucial to gauge how its competitors, including Healthpeak Properties, Sabra Health Care REIT, and National Health Investors, have been performing.
<ul>
<li>The latest earnings announcement from Healthpeak Properties on October 24, 2024 exceeded expectations, with an actual EPS of $0.45 compared to the market's estimate of $0.44, resulting in a 2.27% increase.</li>
<li>Sabra Health Care REIT's earnings on October 31, 2024 exceeded market projections, revealing an EPS of $0.35 compared to the estimated EPS of $0.35, resulting in a 0.0% increase.</li>
<li>On November 05, 2024, National Health Investors unveiled earnings that were below market expectations, with an actual EPS of $1.03 compared to an estimated EPS of $1.08, resulting in a -4.63% decrease.</li>
</ul>
<h3>Comprehensive Analysis: Competitors' Quarterly Earnings and Stock Performance</h3>
This insightful analysis provides an overview of the market's responses to the latest earnings releases from key competitors. It presents the projected and actual earnings per share (EPS) figures for each company, alongside the associated stock prices at the close of the announcement day and the opening of the following trading day.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Date</th>
<th style="text-align: right;">EPS Expected</th>
<th style="text-align: right;">EPS Announced</th>
<th>EPS Change Percent</th>
<th>Stock Price At Close</th>
<th>Stock Price at Next Day Open</th>
<th>Price Change Percent</th>
</tr>
</thead>
<tbody>
<tr>
<td>Welltower</td>
<td>October 28, 2024</td>
<td style="text-align: right;">1.04</td>
<td style="text-align: right;">1.11</td>
<td>6.73%</td>
<td>$130.57</td>
<td>$133.62</td>
<td>2.34%</td>
</tr>
<tr>
<td>Healthpeak Properties</td>
<td>October 24, 2024</td>
<td style="text-align: right;">0.44</td>
<td style="text-align: right;">0.45</td>
<td>2.27%</td>
<td>$23.0</td>
<td>$22.66</td>
<td>-1.48%</td>
</tr>
<tr>
<td>Sabra Health Care REIT</td>
<td>October 31, 2024</td>
<td style="text-align: right;">0.35</td>
<td style="text-align: right;">0.35</td>
<td>0.0%</td>
<td>$19.4</td>
<td>$19.78</td>
<td>1.96%</td>
</tr>
<tr>
<td>National Health Investors</td>
<td>November 05, 2024</td>
<td style="text-align: right;">1.08</td>
<td style="text-align: right;">1.03</td>
<td>-4.63%</td>
<td>$76.73</td>
<td>$76.75</td>
<td>0.03%</td>
</tr>
</tbody>
</table>

<h3>Delving into Peer Revenue Comparison: Estimated vs. Announced</h3>
The table below illustrates a comparison of estimated and announced revenue figures for Welltower's peers. This comparison sheds light on the revenue performance of these companies, providing valuable context to understand their financial standing within the industry.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Estimated Revenue</th>
<th>Announced Revenue</th>
<th>Revenue Surprise Percentage</th>
</tr>
</thead>
<tbody>
<tr>
<td>Welltower</td>
<td>1.95B</td>
<td>2.06B</td>
<td>5.44%</td>
</tr>
<tr>
<td>Healthpeak Properties</td>
<td>688.98M</td>
<td>700.40M</td>
<td>1.66%</td>
</tr>
<tr>
<td>Sabra Health Care REIT</td>
<td>172.34M</td>
<td>178.00M</td>
<td>3.28%</td>
</tr>
<tr>
<td>National Health Investors</td>
<td>79.21M</td>
<td>82.94M</td>
<td>4.72%</td>
</tr>
</tbody>
</table>

To track all earnings releases for Welltower <a href="https://www.benzinga.com/quote/WELL/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

WELL

Welltower: Q3 Earnings Insights

Markets have moved in dramatic fashion post election cycle and sharp moves like this often settle into a new rhythm before continuing.  For this reason, we will consider a strong stock with solid options volume and beefy option premiums.  This allows us to trap the stock through a range of motion as it settles into its new pattern.
Understanding the short iron condor&nbsp;&nbsp;
The short iron condor assumes price action will sit in a range of motion, and while it sits in that range, we will allow the collected premium to erode.&nbsp;
The short iron condor is created by selling a long call spread out of the money and selling a put spread out of the money.&nbsp; The goal is to allow time decay and time premium to erode so that we collect revenue.&nbsp; In that sense, we are paid for sitting still over the passage of time.&nbsp;&nbsp;&nbsp;
Sell to open 1 NFLX 20 Dec 805 CALLS&nbsp;
Buy to open 1 NFLX 20 Dec 810 CALLS&nbsp;
Sell to open 1 NFLX 20 Dec 700 PUTS&nbsp;
Buy to open 1 NFLX 20 Dec 695 PUTS&nbsp;
The total credit is $2.17 at the writing – and it is the maximum profit that the position will yield.&nbsp; The maximum loss is calculated by subtracting the difference between the strikes ($5) here, from the collected premium.&nbsp; $5- $2.17 = $2.83 risk&nbsp;
We choose to sell premium as it carries a higher probability of success as markets will only trend 30% of the time and will sit in ranges 70% of the time.&nbsp; This, of course, is an approximate as price action varies from stock to stock.&nbsp;
The strategy result provides three choices for exiting the trade. 
<ol start="1">
<li>To buy the iron condor back once it gets to an acceptable profit margin for you.  I customarily look for 30% to 50% profit for these kinds of trades. </li>
<li>To buy the iron condor back once it hits your loss threshold as determined by personal risk- this will happen with extreme movement. I customarily look at about 65% though depending on my size, I will choose 50% </li>
<li>To buy the iron condor back into the week before expiration, if all is going well and you have decided to hold the trade into closer to the end of expiration (I have had many a trade go sideways taking it down to the wire and not capturing gains, so I do not advise this). </li>
</ol>
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout-easy-income/?t=be33be9spmirebz88&amp;utm_source=WebRD-1107">We Just Released: The Easy Income Portfolio</a>
Take the guesswork out of investing with handpicked, income-focused stock picks delivered monthly. Start building a steady cash flow with high-yield stocks designed for reliable returns. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout-easy-income/?t=be33be9spmirebz88&amp;utm_source=WebRD-1107">Get Our Picks!</a>
Photo courtesy: Adobe

Opinion

Trading Ideas

Find The Rhythm As This Stock Moves Post-Election

Prominent chipmakers, including Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) and GlobalFoundries Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>), have finalized agreements for substantial U.S. government grants and loans to support their manufacturing efforts, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-11-06/tsmc-globalfoundries-finish-talks-over-billions-in-chips-awards?utm_source=google&amp;utm_medium=bd&amp;cmpId=google&amp;sref=TBDibEcD" rel="noreferrer noopener">cites</a> familiar sources.
This milestone, confirmed by a recent notification from the U.S. Commerce Department to Congress, marks significant progress in implementing the 2022 bipartisan initiative to boost domestic semiconductor production.
Taiwan Semiconductor, which received an initial $6.6 billion in April for its Phoenix, Arizona semiconductor project, and GlobalFoundries, awarded $1.5 billion for its facilities in Malta, New York, and Burlington, Vermont, are among 21 recipients collectively receiving $37 billion in preliminary CHIPS Act funds, Reuters reports.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41780782/why-is-iron-mountain-stock-plunging-on-wednesday" rel="noreferrer noopener">Why Is Iron Mountain Stock Plunging On Wednesday?</a>
Some grant recipients fear potential setbacks after former President Donald Trump returns to office as Trump <a target="_blank" href="https://www.benzinga.com/news/24/11/41780976/chip-stocks-like-nvidia-broadcom-taiwan-semi-gain-after-trump-win-whats-going-on" rel="noreferrer noopener">recently criticized the</a> CHIPS Act on the Joe Rogan podcast, calling it a "bad deal" that subsidizes wealthy corporations. He suggested high tariffs, rather than federal funding, as an alternative to encourage domestic chip production.
Republican House Speaker Mike Johnson also hinted that the GOP might consider repealing the CHIPS Act if they gain majority control. Although he later clarified his remarks, uncertainty lingers among companies awaiting final agreements.
Experts suggest that despite campaign remarks, President-elect Donald Trump is unlikely to repeal the Biden administration's CHIPS and Science Act.
Paul Triolo of Albright Stonebridge <a target="_blank" href="https://www.cnbc.com/2024/11/07/trump-likely-to-uphold-chips-act-despite-his-campaign-rhetoric-experts-say.html" rel="noreferrer noopener">told</a> CNBC that, despite Trump's reservations, there is bipartisan support for advanced manufacturing in the U.S. Economist Adam Posen of the Peterson Institute for International Economics expects Trump may adjust the funding focus but will largely leave the act intact, akin to Biden's retention of Trump-era tariffs on China.
Posen predicts Trump will likely emphasize tariffs over industrial policy expansion if he chooses to adjust the act.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07030308/newplot-3.png" alt="" class="wp-image-634662" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07030308/newplot-3.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07030308/newplot-3-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Taiwan Semiconductor reported a <a target="_blank" href="https://www.benzinga.com/news/24/10/41388050/apples-3nm-push-boosts-taiwan-semis-q3-ai-revenue-set-to-triple-analyst" rel="noreferrer noopener">fiscal third-quarter</a> revenue of 759.69 billion New Taiwan dollars ($23.50 billion), up 39%, topping the $22.4 billion-$23.2 billion guidance and consensus estimate.
The contract chipmaker attributed the quarterly performance to robust smartphone and AI-related demand for its 3nm (which Needham's Charles Shi&nbsp;primarily attributed to Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>)) and 5nm technologies. The&nbsp;gross margin expanded to&nbsp;57.8%, up 350 bps. It expects fourth-quarter revenue of $26.1 billion-$26.9 billion, above the Street consensus of $24.86 billion.
GlobalFoundries reported a <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41745824/short-squeeze-globalfoundries-stock-soars-on-q3-earnings-beat-strong-q4-outlook" rel="noreferrer noopener">fiscal third-quarter</a> 2024 revenue decline of 6% year-on-year to $1.74 billion, beating the&nbsp;consensus estimate of $1.73 billion. The adjusted gross margin declined by 450 bps to 24.7%. It expects fourth-quarter revenue of $1.80 billion—$1.85 billion, versus the&nbsp;$1.73 billion estimate.
Taiwan Semiconductor&nbsp;stock gained over 90% year-to-date, and Globalfoundries&nbsp;lost over 19%.
Price Actions: TSM stock traded higher by 3.97% at $200.90 at the last check on Thursday. GFS traded lower by 2.30%.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41783576/johnson-controls-q3-earnings-north-america-leads-growth-ceo-highlights-record-backlog-for-2025" target="_blank" rel="noreferrer noopener">Johnson Controls Q3 Earnings: North America Leads Growth, CEO Highlights Record Backlog For 2025</a></li>
</ul>
Image via Shutterstock

Government

Regulations

Tech

Media

AAPL

Taiwan Semi and GlobalFoundries Finalize Major US Funding Deals, Eye Growth in Chip Manufacturing

Leerink Partners analyst Michael Cherny downgrades Dentsply Sirona (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) from Outperform to Market Perform.

Downgrades

XRAY

Leerink Partners Downgrades Dentsply Sirona to Market Perform

EPAM Systems, Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>)&nbsp;reported&nbsp;fiscal third-quarter 2024 sales grew 1.3%&nbsp;year over year&nbsp;to $1.17&nbsp;billion, beating the&nbsp;<a href="https://www.benzinga.com/pressreleases/24/11/n41800446/epam-reports-results-for-third-quarter-2024-and-raises-full-year-outlook">analyst consensus&nbsp;estimate of $1.15 billion</a>.
Adjusted EPS of $3.12 beat the&nbsp;<a href="https://www.benzinga.com/earnings">analyst consensus estimate of $2.70</a>. The stock price climbed after the print.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41756372/robinhoods-election-contracts-hit-200-million-trades-on-election-day" target="_blank" rel="noreferrer noopener">Robinhood&#8217;s Election Contracts Hit 200 Million Trades On Election Day</a>
Operating margin grew to 15.2% from 9.9% in the year-ago.&nbsp;
Adjusted income from operations grew by 14% year over year. The margin grew 210 bps to 19.1%.
Cash and equivalents totaled&nbsp;$2.04 billion&nbsp;as of&nbsp;September-end, a decrease of&nbsp;0.1% from&nbsp;$2.04 billion&nbsp;as of&nbsp;December-end. The company&#8217;s long-term debt totaled $25.33 million.
CEO Arkadiy Dobkin highlighted the company&#8217;s role in helping clients modernize through advanced solutions, including GenAI capabilities. Dobkin noted that the recent acquisition of NEORIS underscores EPAM&#8217;s commitment to diversifying its global delivery platform and expanding into new markets to better serve enterprise clients.
Outlook: EPAM Systems lowered its fiscal 2024 revenue outlook to $4.685 billion-$4.695 billion (<a href="https://www.benzinga.com/news/earnings/24/08/40252603/epam-systems-q2-earnings-revenue-and-eps-beat-cuts-annual-revenue-outlook-ceo-highlights-genai-expe" target="_blank" rel="noreferrer noopener">prior $4.590 billion-$4.625 billion</a>) versus the consensus of $4.62 billion. The company also revised the fiscal 2024 outlook for adjusted EPS to $10.73-$10.81 (prior $10.20-$10.40) versus the <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">consensus of $10.29</a>.
EPAM Systems expects fourth-quarter revenue of $1.205 billion-$1.215 billion versus consensus of $1.150 billion and adjusted EPS of $2.70-$2.78 versus&nbsp;consensus of $2.70.
Price Action:&nbsp;EPAM stock is up 16.6% to $235.50 at last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41773589/apple-signals-profit-risks-in-ai-and-vr-shift-what-it-means-for-investors" target="_blank" rel="noreferrer noopener">Apple Signals Profit Risks in AI and VR Shift: What It Means for Investors?</a></li>
</ul>

Guidance

EPAM

EPAM Q3 Earnings: Beats Expectations, Rising Margins, CEO Flags NEORIS Acquisition

Wells Fargo analyst Yanan Zhu maintains Ionis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>) with a Overweight and lowers the price target from $82 to $77.

IONS

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $77

Across the United States, renters are increasingly caught between a rock and a hard place as rent surges and wages barely budge. By the end of 2022, 50% of renter households were classified as "cost-burdened," spending over 30% of their income on housing and utilities, while 12.1 million households crossed a threshold most would find untenable, devoting more than half of their income to rent.&nbsp;
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
</ul>
The shortage of affordable housing compounds the issue, with the nation having lost over 2.1 million rental units priced under $600 since 2012. This situation has spurred a financial scramble, pushing many households to work extra hours or juggle multiple jobs to cover rent.
Recent reports paint a sobering picture: rent has surged 21% since 2001, yet renter incomes have risen by only 2% in the same period, leaving people grappling with affordability.
This discrepancy pressures people to stretch budgets in ways that leave little room for other expenses. Zillow's Kara Ng notes, "Generally, the more you spend on essentials like shelter, the less you spend on other things." For many, that means cutting corners and sacrificing everything from entertainment to savings.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
A new analysis by Self Financial reveals that the typical renter works an average of 50 hours each month to pay rent. Fifty hours is roughly 30% of a full-time month based on a standard 40-hour workweek. In some locations, these numbers climb even higher.
In states like California and Florida, where average monthly rents reach $2,493 and $2,033 respectively, renters must log upward of 80-100 hours at median wage rates just to meet housing costs. Even in Texas, with a lower average rent of $1,720, it still takes 52.9 hours at $32.54 per hour to cover monthly rent.&nbsp;
This squeeze is driving a marked increase in housing instability. In 2023, homelessness rose to 653,100 people nationwide – a historic high, according to Harvard's Joint Center for Housing Studies, underscoring a rising tide of financial insecurity.
See Also: Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
Although rent growth slowed in 2023 to a modest 0.4%, the market remains far from affordable. Median rents have risen by one-third since the pandemic began, with rents in nearly all major metropolitan areas showing year-over-year increases.&nbsp;
Meanwhile, the window of opportunity for affordable rentals continues to shrink: only one-third of renters now pay less than $1,000 per month, the lowest proportion on record, according to Redfin. Staying put may be wise for those who pay less than $1,000, as only 7.5% of available listings now fall below this price point.
On the bright side, some relief may be on the horizon. With an oversupply of new apartments in cities, especially in the Sun Belt, landlords are beginning to offer rental concessions. "We're catching a break on the rental market right now," says Redfin's Chen Zhao, optimistic that the country may gradually "chip away at the affordability issue."
Read Next:
<ul>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

Rent Soars, Pay Lags: Why Millions Are Working 50+ Hours Just to Afford Housing, According to New Report

Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Overweight and raises the price target from $100 to $105.

GILD

Wells Fargo Maintains Overweight on Gilead Sciences, Raises Price Target to $105

Cantor Fitzgerald analyst Deepak Mathivanan maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Overweight and lowers the price target from $2530 to $2300.

MELI

Cantor Fitzgerald Maintains Overweight on MercadoLibre, Lowers Price Target to $2300

Wells Fargo analyst Finian O'Shea maintains Carlyle Secured Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBD#NASDAQ">CGBD</a>) with a Equal-Weight and lowers the price target from $17 to $16.

CGBD

Wells Fargo Maintains Equal-Weight on Carlyle Secured Lending, Lowers Price Target to $16

Steven Madden, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>) shares are trading lower on Thursday. The company reported third-quarter adjusted EPS of 91 cents, <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">beating the Wall Street View of 89 cents.</a>
Quarterly revenues of&nbsp;$624.7 million&nbsp;surpassed the analyst consensus of&nbsp;$607.9 million. Revenue <a href="https://www.benzinga.com/earnings">increased&nbsp;13.0%&nbsp;year over year</a>.
Direct-to-consumer revenue was&nbsp;$125.5&nbsp;million, a&nbsp;7.8%&nbsp;increase year over year. Revenue for the wholesale business was&nbsp;$495.7&nbsp;million, a&nbsp;14.4%&nbsp;increase year over year.
Gross profit as a percentage of revenue was&nbsp;41.5%&nbsp;compared to&nbsp;42.1%&nbsp;in the same period of 2022. Adjusted operating expenses as a percentage of revenue were&nbsp;27.9%&nbsp;compared to&nbsp;27.0%&nbsp;in the same period of 2022.
The company ended the quarter with 282&nbsp;company-operated brick-and-mortar retail stores and five e-commerce websites, as well as 67 company-operated concessions in international markets.
As of Sept. 30, cash and equivalents and short-term investments totaled $150.5 million. Inventory totaled $268.7 million as of the same date.
Dividend: The company approved a quarterly cash dividend of 21 cents per share. The dividend is payable on Dec. 27, to stockholders of record on Dec. 13.
Buyback: The company repurchased shares worth $20.2 million, which includes shares acquired through the net settlement of employees&#8217; stock awards.
Outlook:&nbsp;Steve Madden raised its FY24 revenue guidance to a 13%-14% increase (up from 11%-13%) and now expects adjusted EPS to be in the range of $2.62-$2.67, up from the prior range of $2.55-$2.65. The consensus <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">estimate for adjusted EPS is $2.64</a>.
Edward Rosenfeld, chairman and chief executive officer, said, &#8220;This performance was driven by outstanding growth in the accessories and apparel categories – including another quarter of exceptional performance in Steve Madden handbags and a strong contribution from newly acquired Almost Famous – and robust top line gains in international markets and direct-to-consumer channels, demonstrating our team&#8217;s strong execution of our key strategic initiatives.&#8221;
Price Action: SHOO shares are up 1.1% at $44.75 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41803738" target="_blank" rel="noreferrer noopener">Invesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here&#8217;s How Some Of Their Peers Have Performed In The Past Year</a></li>
</ul>
Photo via Wikimedia Commons

Mid Cap

SHOO

Steve Madden Q3 Earnings Top Estimates As Revenue Jumps 13%, Lifts 2024 Outlook

Wells Fargo analyst Finian O'Shea maintains BlackRock TCP Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCPC#NASDAQ">TCPC</a>) with a Underweight and raises the price target from $7.5 to $8.

TCPC

Wells Fargo Maintains Underweight on BlackRock TCP Cap, Raises Price Target to $8

– NKTR-255 administered post completion of concurrent chemoradiation and in combination with durvalumab demonstrated statistically significant lymphocyte recovery compared to historical controls at week 8 –
– Pharmacodynamic data show NKTR-255 increased NK cell proliferation and markers of NK cell activation &nbsp;–
SAN FRANCISCO, Nov. 7, 2024 /PRNewswire/ --&nbsp;Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) and collaborators at The University of Texas MD Anderson Cancer Center today presented late-breaking results from a Phase 2 study evaluating NKTR-255 for the treatment of radiation induced lymphopenia after concurrent chemoradiation in locally advanced non-small cell lung cancer (NSCLC) patients at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting.

Biotech

General

NKTR

Nektar And Collaborators Present Late-Breaking Results From Phase 2 Study Of NKTR-255 For The Treatment Of Radiation Induced Lymphopenia In Locally Advanced Non-Small Cell Lung Cancer Patients At SITC Annual Meeting; Demonstrated Statistically Significant Lymphocyte Recovery Compared To Historical Controls At Week 8

Under Armour Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UA#NYSE">UA</a>) shares surged on Thursday after the company reported better-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41802141/under-armour-reports-second-quarter-2025-results-raises-fiscal-2025-outlook" rel="noreferrer noopener">second-quarter results</a>.
The company reported a 10.7% year-over-year decline in net revenue to $1.399 billion, surpassing the $1.38 billion analyst consensus. Adjusted EPS was $0.30, <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">above the consensus of $0.20.</a>
Wholesale revenue decreased 12% year over year to $826 million, and direct-to-consumer revenue was down 8% to $550 million.
Apparel revenue slipped 12% year over year, Footwear revenue dropped 11%, and Accessories revenue rose 2%. North American revenue decreased 13% to $863 million, and international revenue declined 6% to $538 million.
Gross profit decreased 7% to $696.13 million, and the gross margin expanded 200 basis points to 49.8%.
Operating income totaled $173 million; adjusted for one-time items, it was $166 million.
Selling, general, and administrative expenses dropped 15% YoY to $520 million; adjusted expenses fell 13% to $530 million, excluding $13 million in insurance recovery and $3 million in restructuring costs.
As of September end, the company held $531 million in cash and equivalents. Inventory was $1.1 billion, a 3% decrease.
In May 2024, Under Armour announced a restructuring plan, later expanded in September to include closing its Rialto, California facility, raising the cost range to $140 million &#8211; $160 million. As of the second fiscal quarter, it incurred $40 million in charges and expenses, with remaining expenses expected through 2026.
&#8220;Our second quarter fiscal 2025 performance demonstrates that our strategy to reconstitute the Under Armour brand and establish a more premium position in the marketplace is gaining traction. With better-than-expected results, we are pleased to raise our full-year profitability outlook while simultaneously increasing marketing investments to amplify our brand,&#8221; commented Under Armour President and CEO Kevin Plank.
2025 Outlook Updated: Under Armour raised its adjusted EPS forecast from $0.19 &#8211; $0.21 to $0.24 &#8211; $0.27. Revenue is still expected to decline by a low double-digit percentage, with <a href="https://www.benzinga.com/calendars/guidance">North America projected to drop 14% &#8211; 16%.</a>
The company expects gross margin to be up 125 to 150 basis points compared to the prior expectation of a 75 to 100 basis point improvement. Adjusted operating income is expected to be $165 million to $185 million, compared to the prior expectation of $140 million to $160 million.
Price Action: UAA shares are trading higher by 25.1% at $10.09 at the last check Thursday.
Photo via Shutterstock

Large Cap

Movers

Under Armour CEO Signals 'Premium' Brand Transformation After Strong Q2 Performance, Stock Soars

Aurora Cannabis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) recently reported strong quarterly earnings that outpaced market expectations, despite a downturn across the cannabis sector.&nbsp;
Aurora's share price fell 18% following the earnings report, reflecting broader sector pressures, with the MSOS ETF down 29%. As of this morning, November 7, 2024, Aurora's stock is trading at $5.25 in pre-market, showing a 2.54% increase from its previous close.
"Despite having no U.S. exposure, Aurora surpassed consensus estimates on sales and EBITDA, encouraging guidance for the December quarter," observed analyst Pablo Zuanic of Zuanic &amp; Associates. 
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">International Medical Cannabis Growth Drives Revenue</h3>
Aurora's international medical cannabis (MMJ) business significantly bolstered its revenue, with European sales doubling quarter-over-quarter to $20 million, led by strong demand in <a href="https://www.benzinga.com/topic/germany-cannabis">Germany</a> and Poland.&nbsp;
Australian MMJ sales also rose from $9.3 million to $15.1 million, benefiting from an August inventory drawdown following the MedReleaf <a href="https://www.benzinga.com/topic/australia-cannabis">Australia</a> acquisition.
<h3 class="wp-block-heading">Profit Margins Reflect International Expansion</h3>
The company's profitability has improved as higher-margin international markets now make up 57% of Aurora's global MMJ sales from 42% a year ago. This <a href="https://www.benzinga.com/markets/cannabis/24/11/41774692/aurora-cannabis-reports-strong-q2-growth-driven-by-international-medical-marijuana-sales">boosted adjusted cash gross margins to 68%</a> for MMJ products, a 5% increase year-over-year, with total company margins rising 450 basis points to over 55%.&nbsp;
Operating expenses remained steady at $35 million per quarter, resulting in an EBITDA margin increase from 5% to 12% year-over-year.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/11/41793174/cannabis-stocks-collapse-after-trump-win-major-players-see-double-digit-declines-at-wednesdays-c"> Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday&#8217;s Close</a>
<h3 class="wp-block-heading">December Quarter Guidance And Challenges</h3>
Aurora anticipates stable sales and EBITDA for the December quarter, exceeding consensus by 9% and 90%, respectively. The outlook includes a seasonal decline in its propagation business but projects positive EBITDA and free cash flow, supported by<a href="https://www.benzinga.com/markets/cannabis/24/11/41774692/aurora-cannabis-reports-strong-q2-growth-driven-by-international-medical-marijuana-sales"> Aurora's net cash position</a> of $27 million (cash of $85 million against $58 million in Bevo-related debt).&nbsp;
Zuanic noted that international growth remains promising, although "shipments can be inconsistent, making end-market growth predictions difficult."
<h3 class="wp-block-heading">Valuation Compared To Peers</h3>
According to Zuanic, with a valuation of 1.4x its annualized sales, Aurora appears undervalued compared to competitors Tilray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) and Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>), which trade at multiples of 3-4x sales.&nbsp;
"Though business models differ, operational trends and lower valuation offer potential upside for ACB shares," Zuanic commented. Aurora's combination of higher-margin international revenue and more conservative valuation may present an opportunity amid sector volatility. 
Read Next:<a href="https://www.benzinga.com/markets/cannabis/24/11/41791833/curaleaf-q3-results-strong-margins-but-44m-loss-whats-next-for-investors"> Curaleaf Q3 Results: Strong Margins But $44M Loss, What&#8217;s Next For Investors?</a>

Analyst Color

Cannabis

Market Summary

Eurozone

Commodities

Global

TLRY

Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?

Deep-pocketed investors have adopted a bullish approach towards Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GOOGL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Alphabet. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 2 are puts, totaling $124,452, and 7 are calls, amounting to $474,678.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $360.0 for Alphabet over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Alphabet's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Alphabet's whale activity within a strike price range from $150.0 to $360.0 in the last 30 days. 
<h3>Alphabet Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730992549_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$23.0</td>
<td>$23.0</td>
<td>$23.0</td>
<td>$160.00</td>
<td>$172.5K</td>
<td>1.6K</td>
<td>75</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$27.35</td>
<td>$27.3</td>
<td>$27.35</td>
<td>$185.00</td>
<td>$103.9K</td>
<td>418</td>
<td>53</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.3</td>
<td>$1.29</td>
<td>$1.29</td>
<td>$200.00</td>
<td>$71.5K</td>
<td>89.3K</td>
<td>1.7K</td>
</tr>
<tr>
<td>GOOGL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$9.7</td>
<td>$9.65</td>
<td>$9.65</td>
<td>$180.00</td>
<td>$70.4K</td>
<td>386</td>
<td>103</td>
</tr>
<tr>
<td>GOOGL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$9.0</td>
<td>$8.95</td>
<td>$9.0</td>
<td>$175.00</td>
<td>$54.0K</td>
<td>260</td>
<td>60</td>
</tr>
</tbody>
</table>

<h3>About Alphabet</h3>
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV, YouTube Music among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform, or GCP, accounts for roughly 10% of Alphabet's revenue with the firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) making up the rest.
In light of the recent options history for Alphabet, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Alphabet</h3>
<ul>
<li>Currently trading with a volume of 3,482,171, the GOOGL's price is up by 0.96%, now at $178.2. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<h3>Professional Analyst Ratings for Alphabet</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $203.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $210. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Alphabet, targeting a price of $220. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Alphabet with a target price of $210. 
&#x2A; Maintaining their stance, an analyst from Bernstein continues to hold a Market Perform rating for Alphabet, targeting a price of $185. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Neutral with a new price target of $190.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Alphabet options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

GOOGL

Market Whales and Their Recent Bets on GOOGL Options

In a report released today, Joe Feldman from Telsey Advisory maintained a Hold rating on Under Armour (UAA – Research Report), with a price target ...

Telsey Advisory Sticks to Their Hold Rating for Under Armour (UAA)

Seaport Global analyst Mitch Kummetz maintained a Hold rating on Under Armour (UAA – Research Report) today. The company's shares closed yesterday ...

Under Armour (UAA) Gets a Hold from Seaport Global

Notable companies reporting before tomorrow's open, with earnings consensus, include Transdigm (TDG), consensus $9.32… Becton Dickinson (BDX), cons...

Notable companies reporting before tomorrow's open

Under Armour Non-GAAP EPS of $0.30 beats by $0.11, revenue of $1.4B beats by $20M

Reports Q2 revenue $1.4B, consensus $1.38B. Inventory decreased 3% to $1.1B. "Our second quarter fiscal 2025 performance demonstrates that our stra...

Under Armour reports Q2 adjusted EPS 30c, consensus 20c

Consensus 24c. Sees FY25 revenue down low double-digit percentage range. The company said, "Capital expenditures are expected to be between $190 an...

Under Armour raises FY25 adjusted EPS view to 24c-27c from 19c-21c

Under Armour rallies on FQ2 beat, raised FY profit guidance

Under Armour (UAA) is up 27.8%, or $2.44 to $11.19. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

Under Armour rises 27.8%

Under Armour (UAA) is up 18.1%, or $1.58 to $10.33. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

Under Armour rises 18.1%

DDOG

ELAN

GDRX

KVUE

MRNA

PENN

PLNT

PLTK

PZZA

USFD

YETI

Press Releases

UNDER ARMOUR REPORTS FOURTH QUARTER AND FULL-YEAR FISCAL 2024 RESULTS; PROVIDES INITIAL FISCAL 2025 OUTLOOK

USA FOOTBALL AND UNDER ARMOUR FORM MULTI-YEAR PARTNERSHIP TO SUPPORT U.S. NATIONAL TEAMS AND GROW THE GAME OF FOOTBALL

University of Maryland and Under Armour Announce 12-Year Extension of Iconic Partnership

UNDER ARMOUR ANNOUNCES AGREEMENT TO SETTLE CLASS ACTION LITIGATION

UNDER ARMOUR ANNOUNCES FIRST QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE

UNDER ARMOUR ANNOUNCES ERIC LIEDTKE AS EXECUTIVE VICE PRESIDENT OF BRAND STRATEGY

UNDER ARMOUR REPORTS FIRST QUARTER 2025 RESULTS; UPDATES FISCAL 2025 OUTLOOK

UNDER ARMOUR ANNOUNCES UPDATE TO ITS RESTRUCTURING PLAN AND FISCAL 2025 OUTLOOK

UNDER ARMOUR ANNOUNCES SECOND QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE

UNDER ARMOUR REPORTS SECOND QUARTER 2025 RESULTS; RAISES FISCAL 2025 OUTLOOK

Amer Sports

Columbia Sportswear Company - Common Stock

Columbia Sportswear

Capri Holdings

Carter's

Dogness (International) Corporation - Class A Common Stock

Dogness (Intl)

FIGS

Fossil Group

G-III Apparel Group

Hanesbrands

Kontoor Brands

Lakeland Industries

Lanvin Group Holdings Limited Ordinary Shares

Lanvin Gr Hldgs

Levi Strauss

Lululemon Athletica

Movado Group

Oxford Industries

PLBY Group

Ralph Lauren

Superior Group of Companies, Inc. - Common Stock

Superior Gr of Cos

Tapestry

Vera Bradley

Ermenegildo Zegna

Telsey Advisory Group

TD Cowen

BMO Capital

Wedbush

WIIM

Under Armour shares are trading higher after the company reported better-than-expected Q2 EPS and sales.

도널드 트럼프가 제안한 수입 관세가 운동화 제조업체와 소매업체에 큰 영향을 미칠 것이라는 우려가 운동화 업계를 휩쓸고 있다. 이러한 잠재적인 정책은 특히 <a href="https://www.benzinga.com/news/24/11/41795320/trumps-20-tariff-plans-could-unleash-wave-of-spending-on-big-ticket-buys-in-holiday-quarter-says-eco">아시아 제조 허브에 크게 의존</a>하는 기업들에게 영향을 미칠 수 있다.
무슨 일이 일어났을까? <a href=""https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft"">트럼프 대통령이 모든 수입품에 20% 관세를 부과</a>하고 특히 중국산 제품에 60%의 초고율 관세를 부과하겠다고 밝힌 후 업계 리더들은 충격에 대비하고 있다. 이미 상당한 수입 관세를 부담하고 있는 신발 부문은 생산 비용이 더욱 급증할 수 있다.
주요 운동복 기업 주가가 하락하면서 이러한 우려는 미국 증시에 반영되었다. 나이키(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) 주가는 3.41% 하락했으며, 아디다스 (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADDYY#OTC">ADDYY</a>)도 3.62% 하락했다. 언더아머(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>)는 1.35% 하락했고, Vans 모회사인 VF 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>)도 2.67% 하락했다.
댄 셔리던(Dan Sheridan) 브룩스 러닝 CEO는 <a href="https://finance.yahoo.com/news/starbucks-ceo-no-plans-to-move-hq-out-of-seattle-as-the-company-attempts-a-turnaround-214425009.html">야후 파이낸스</a>와 인터뷰에서 &#8220;이것은 전체 산업에 큰 역풍이 될 것&#8221;이라며 현재 신발 회사들이 중국산 수입품에 대한 20% 관세와 베트남산 수입품에 대한 약 27%의 관세를 감당하고 있다고 지적했다.
벤징가는 영향을 받은 회사에 연락을 했지만 즉각적인 응답을 받지는 못했다.
왜 중요할까? 운동복 산업의 취약성은 중국, 베트남, 인도네시아 등 아시아 제조 허브에 대한 의존도가 높기 때문이다. 추가 관세가 부과되면 회사들은 더 높은 비용을 흡수하거나 소비자에게 전가해야 할 수 있다.
하지만 일부 회사들은 시장 불확실성 속에서도 탄력성을 보였다. 푸마(OTC:<a class="ticker" href="https://www.benzinga.com/stock/PMMAF#OTC">PMMAF</a>) 주가는 2.10% 상승했으며 호카오네오네(Hoka One One)의 모회사인 데커스 아웃도어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>)도 0.67% 상승했다.
더 읽기: 
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ED%8A%B8%EB%9F%BC%ED%94%84%EC%9D%98-20-%EA%B4%80%EC%84%B8-%EA%B3%84%ED%9A%8D-%EC%97%B0%EB%A7%90-%EA%B3%A0%EA%B0%80%ED%92%88-%EC%86%8C%EB%B9%84-%ED%8F%AD%EB%B0%9C-%EC%9C%A0%EB%B0%9C%ED%95%A0/">트럼프의 20% 관세 계획, 연말 고가품 소비 폭발 유발할 수도, 경제학자 저스틴 울퍼스</a></li>
</ul>
이미지: Dall-E로 생성
면책 조항: 이 기사는 부분적으로 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">벤징가 뉴로(Benzinga Neuro)</a>의 도움을 받아 작성되었으며, 벤징가 에디터들이 검토한 후 게시했습니다.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Under Armour

뉴스

에 대한 최신 뉴스 Under Armour (NYSE:UAA) 주식

목요일, 11월 07, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌